CA2286293C - A method for extracting quantitative information relating to an influence on a cellular response - Google Patents

A method for extracting quantitative information relating to an influence on a cellular response Download PDF

Info

Publication number
CA2286293C
CA2286293C CA002286293A CA2286293A CA2286293C CA 2286293 C CA2286293 C CA 2286293C CA 002286293 A CA002286293 A CA 002286293A CA 2286293 A CA2286293 A CA 2286293A CA 2286293 C CA2286293 C CA 2286293C
Authority
CA
Canada
Prior art keywords
leu
val
gly
glu
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002286293A
Other languages
English (en)
French (fr)
Other versions
CA2286293A1 (en
Inventor
Ole Thastrup
Sara Petersen Bjorn
Soren Tullin
Kasper Almholt
Kurt Scudder
Bernard Robert Terry
Per Olof Gunnar Arkhammer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisher BioImage ApS
Original Assignee
BioImage AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8092994&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2286293(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by BioImage AS filed Critical BioImage AS
Priority to CA002450698A priority Critical patent/CA2450698A1/en
Publication of CA2286293A1 publication Critical patent/CA2286293A1/en
Application granted granted Critical
Publication of CA2286293C publication Critical patent/CA2286293C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5035—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on sub-cellular localization
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
    • G01N2333/43595—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from coelenteratae, e.g. medusae
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CA002286293A 1997-04-07 1998-04-07 A method for extracting quantitative information relating to an influence on a cellular response Expired - Lifetime CA2286293C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002450698A CA2450698A1 (en) 1997-04-07 1998-04-07 A method for screening substances for effect on camp levels based on intracellular translocation of pka

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK0392/97 1997-04-07
DK39297 1997-04-07
PCT/DK1998/000145 WO1998045704A2 (en) 1997-04-07 1998-04-07 A method for extracting quantitative information relating to an influence on a cellular response

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA002450698A Division CA2450698A1 (en) 1997-04-07 1998-04-07 A method for screening substances for effect on camp levels based on intracellular translocation of pka

Publications (2)

Publication Number Publication Date
CA2286293A1 CA2286293A1 (en) 1998-10-15
CA2286293C true CA2286293C (en) 2004-04-06

Family

ID=8092994

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002286293A Expired - Lifetime CA2286293C (en) 1997-04-07 1998-04-07 A method for extracting quantitative information relating to an influence on a cellular response

Country Status (11)

Country Link
US (3) US6518021B1 (OSRAM)
EP (3) EP0986753B2 (OSRAM)
JP (1) JP2001522454A (OSRAM)
AT (3) ATE269975T1 (OSRAM)
AU (1) AU6820998A (OSRAM)
CA (1) CA2286293C (OSRAM)
DE (4) DE1199564T1 (OSRAM)
DK (2) DK0986753T4 (OSRAM)
ES (2) ES2173573T5 (OSRAM)
PT (2) PT986753E (OSRAM)
WO (1) WO1998045704A2 (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015066706A2 (en) 2013-11-04 2015-05-07 Montana Molecular Llc GENETICALLY ENCODED FLUORESCENT SENSORS FOR DETECTING LIGAND BIAS AND INTRACELLULAR SIGNALING THROUGH cAMP PATHWAYS

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2177922T3 (es) 1996-01-26 2002-12-16 Virco Bvba Metodo de valoracion la quimioterapia de pacientes hiv-positivos basado en la sensibilidad fenotipica a los farmacos de las cepas de hiv delpaciente.
US7062219B2 (en) * 1997-01-31 2006-06-13 Odyssey Thera Inc. Protein fragment complementation assays for high-throughput and high-content screening
US6416959B1 (en) 1997-02-27 2002-07-09 Kenneth Giuliano System for cell-based screening
US6759206B1 (en) 1997-02-27 2004-07-06 Cellomics, Inc. System for cell-based screening
US7853411B2 (en) 1997-02-27 2010-12-14 Cellomics, Inc. System for cell-based screening
DK0986753T4 (da) * 1997-04-07 2005-12-19 Bioimage As Fremgangsmåde til uddragning af kvantitativ information, hvad angår en påvirkning af et cellulært respons
US7160687B1 (en) 1997-05-29 2007-01-09 Cellomics, Inc. Miniaturized cell array methods and apparatus for cell-based screening
US6235512B1 (en) * 1997-07-01 2001-05-22 Tularik Inc. IKK-α proteins, nucleic acids and methods
US20050221280A1 (en) 1998-02-02 2005-10-06 Odyssey Thera, Inc. Protein-protein interactions for pharmacological profiling
US20030036855A1 (en) 1998-03-16 2003-02-20 Praelux Incorporated, A Corporation Of New Jersey Method and apparatus for screening chemical compounds
US6388788B1 (en) 1998-03-16 2002-05-14 Praelux, Inc. Method and apparatus for screening chemical compounds
AU765703B2 (en) * 1998-03-27 2003-09-25 Bruce J. Bryan Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
US6037133A (en) * 1998-04-17 2000-03-14 Clontech Laboratories, Inc. IκBEGFP constructs, cell lines and methods of use
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
US8680059B2 (en) * 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US6844315B2 (en) * 1998-05-20 2005-01-18 Erasmus Universiteit Rotterdam Immunoregulator
AU6189599A (en) * 1998-10-15 2000-05-08 Bioimage A/S An improved method for extracting quantitative information relating to an influence on a cellular response
WO2000023091A2 (en) * 1998-10-15 2000-04-27 Bioimage A/S Specific therapeutic interventions obtained by interference with redistribution and/or targeting of cyclic nucleotide phosphodiesterases of i-kappa-b kinases
GB9901072D0 (en) * 1999-01-19 1999-03-10 Imp Cancer Res Tech Methods for detecting changes to a macromolecular component of a cell
IL144797A0 (en) * 1999-02-26 2002-06-30 Cellomics Inc A system for cell-based screening
DE19915310A1 (de) * 1999-04-03 2000-10-05 Bayer Ag Diffusionskontrollierende Sensorschicht
DE69906253D1 (de) * 1999-04-29 2003-04-30 Univ Erasmus Bestimmung von Analytbeweglichkeit
US6743576B1 (en) 1999-05-14 2004-06-01 Cytokinetics, Inc. Database system for predictive cellular bioinformatics
US20030228565A1 (en) * 2000-04-26 2003-12-11 Cytokinetics, Inc. Method and apparatus for predictive cellular bioinformatics
US6651008B1 (en) 1999-05-14 2003-11-18 Cytokinetics, Inc. Database system including computer code for predictive cellular bioinformatics
AU4847100A (en) * 1999-05-14 2000-12-05 Cytokinetics, Inc. Method and apparatus for predictive cellular bioinformatics
US7151847B2 (en) 2001-02-20 2006-12-19 Cytokinetics, Inc. Image analysis of the golgi complex
EP1055929A1 (en) * 1999-05-26 2000-11-29 Tibotec N.V. Means and methods for drug discovery and the phenotypic characterisation of cells
US6573059B1 (en) * 1999-06-04 2003-06-03 Rmf Dictagene S.A. Use of the regulatory subunit of the camp dependent protein kinase (PKA) from dictyostelium for camp measurements
AU5870800A (en) * 1999-06-09 2000-12-28 Ljl Biosystems, Inc. Cell-signaling assays
US6673554B1 (en) * 1999-06-14 2004-01-06 Trellie Bioinformatics, Inc. Protein localization assays for toxicity and antidotes thereto
AU7131900A (en) * 1999-06-21 2001-01-09 Cellomics, Inc. A system for cell-based screening
US6121047A (en) * 1999-07-21 2000-09-19 Isis Pharmaceuticals Inc. Antisense modulation of SHP-1 expression
US6489151B1 (en) * 2000-03-27 2002-12-03 The Research Foundation Of State University Of New York Biologically active alternative form of the IKKα IκB kinase
EP1300418A1 (en) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Gene regulation by oligopeptides
KR100414641B1 (ko) * 2000-04-07 2004-01-13 동부한농화학 주식회사 형질전환식물체의 생체분석방법 및 그를 이용한 시스템
WO2001079526A2 (en) * 2000-04-17 2001-10-25 Bioimage A/S Live cell procedures to identify compounds modulating intracellular distribution of phosphodiesterase (pde) enzymes
WO2001081917A2 (en) * 2000-04-26 2001-11-01 Bioimage A/S Chemical signal enhancement of dynamic intensity-based intracellular protein- and fluorophore-based redistribution assays for drug screening
AU2001270126A1 (en) * 2000-06-23 2002-01-08 Cytokinetics, Inc. Image analysis for phenotyping sets of mutant cells
CA2414626A1 (en) 2000-07-04 2002-01-10 Bioimage A/S A method for extracting quantitative information relating to interactions between cellular components
US7625951B2 (en) 2000-07-13 2009-12-01 University Of Kentucky Research Foundation Stimuli-responsive hydrogel microdomes integrated with genetically engineered proteins for high-throughput screening of pharmaceuticals
DE10037759A1 (de) * 2000-08-03 2002-07-04 Gruenenthal Gmbh Screeningverfahren
KR100414781B1 (ko) * 2000-11-24 2004-01-13 재단법인서울대학교산학협력재단 ＮＦ-κＢ 발현을 인간 피부세포에서 정량적으로 측정하기위한 안정한 분석시스템 및 그의 용도
US7218764B2 (en) 2000-12-04 2007-05-15 Cytokinetics, Inc. Ploidy classification method
US6956961B2 (en) 2001-02-20 2005-10-18 Cytokinetics, Inc. Extracting shape information contained in cell images
US7016787B2 (en) 2001-02-20 2006-03-21 Cytokinetics, Inc. Characterizing biological stimuli by response curves
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
US7244614B2 (en) 2001-08-01 2007-07-17 Cellomics, Inc. Fusion proteins and assays for molecular binding
WO2003050535A2 (de) * 2001-12-10 2003-06-19 Evotec Oai Ag Verfahren zur bestimmung von einflüssen unphysiologischer verbindungen, deren derivate und abbauprodukte auf organismen, organe und zellen
US7176303B2 (en) * 2003-11-06 2007-02-13 Isis Pharmaceuticals, Inc. Modulation of STAT5 expression
US7786084B2 (en) * 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
US20080242837A1 (en) * 2001-12-21 2008-10-02 Khan Nisar A Peptide compositions
US20030220257A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of trauma
US20080318871A1 (en) * 2001-12-21 2008-12-25 Khan Nisar A Treatment of neurological disorders
US7560433B2 (en) 2001-12-21 2009-07-14 Biotempt B.V. Treatment of multiple sclerosis (MS)
CA2413475C (en) 2002-04-25 2010-07-27 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Zap-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (cll/sll)
GB0216674D0 (en) * 2002-07-18 2002-08-28 Amersham Biosciences Uk Ltd Functional screening method
US8168568B1 (en) 2003-03-10 2012-05-01 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Combinatorial therapy for protein signaling diseases
EP1646926A2 (en) 2003-07-18 2006-04-19 Cytokinetics, Inc. Characterizing biological stimuli by response curves
US20050014217A1 (en) 2003-07-18 2005-01-20 Cytokinetics, Inc. Predicting hepatotoxicity using cell based assays
US7235353B2 (en) 2003-07-18 2007-06-26 Cytokinetics, Inc. Predicting hepatotoxicity using cell based assays
US20050060100A1 (en) * 2003-09-15 2005-03-17 Becton Dickinson And Company Computer software and algorithms for systems biologically linked to cellular phenotype
US20050059083A1 (en) * 2003-09-15 2005-03-17 Becton Dickinson And Company High throughput method to identify ligands for cell attachment
US20090227505A1 (en) * 2004-01-07 2009-09-10 Biotempt B.V. Methods and uses for protein breakdown products
US8586294B2 (en) 2004-05-18 2013-11-19 The Board Of Trustees Of The Leland Stanford Junior University Detection of protein translocation by beta-galactosidase reporter fragment complementation
US7323318B2 (en) 2004-07-15 2008-01-29 Cytokinetics, Inc. Assay for distinguishing live and dead cells
US8084260B2 (en) * 2004-11-24 2011-12-27 Applied Biosystems, Llc Spectral calibration method and system for multiple instruments
JP4846799B2 (ja) * 2005-07-05 2011-12-28 バイオテンプト ベー．フェー． 腫瘍の治療
US20080227131A1 (en) * 2005-10-28 2008-09-18 Ge Healthcare Uk Limited Signalling Assay and Cell Line
WO2008018905A2 (en) * 2006-01-17 2008-02-14 Cellumen, Inc. Method for predicting biological systems responses
EP1864692A1 (en) * 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
US8114615B2 (en) 2006-05-17 2012-02-14 Cernostics, Inc. Method for automated tissue analysis
US20100112602A1 (en) * 2006-11-10 2010-05-06 Taylor Lansing D Protein-Protein Interaction Biosensors and Methods of Use Thereof
US20100178652A1 (en) * 2007-01-05 2010-07-15 Litherland Sally A Materials and Methods for the Detection, Prevention and Treatment of Autoimmune Disease
PT2120991E (pt) * 2007-02-12 2014-05-02 Biotempt Bv Tratamento d a hemorragia traumática com oligopéptidos curtos
US20080217002A1 (en) * 2007-03-07 2008-09-11 Floyd Randolph Simonds Sand control screen having a micro-perforated filtration layer
JP5438962B2 (ja) * 2008-12-25 2014-03-12 シスメックス株式会社 細胞画像表示装置
US8574837B2 (en) 2008-12-29 2013-11-05 President And Fellows Of Harvard College System for screening agonists/antagonists of cellular signaling pathways
KR101088605B1 (ko) 2009-06-30 2011-11-30 한국산업기술대학교산학협력단 2대의 카메라를 이용한 세포 조작 방법
JP5089713B2 (ja) * 2010-01-18 2012-12-05 シャープ株式会社 画像圧縮装置、圧縮画像出力装置、画像圧縮方法、コンピュータプログラム及び記録媒体
ES2739623T3 (es) 2011-03-17 2020-02-03 Cernostics Inc Sistemas y composiciones para diagnosticar el esófago de Barrett y métodos para usarlos
EP2825887A4 (en) 2012-03-15 2015-08-19 Montana Molecular Llc GENETICALLY-CODED, FLUORESCENT SENSORS FOR THE DETECTION OF INTRA-CELLULAR SIGNALS BY DIACYLGLYCEROL SIGNAL PATHS
EP2682187B1 (en) * 2012-07-02 2017-09-13 Molecular Devices, LLC Selection method and apparatus
DE102014012130B3 (de) 2014-08-13 2015-03-05 Alfred-Wegener-Institut, Helmholtz-Zentrum für Polar- und Meeresforschung Nachweisverfahren unter Verwendung von rekombinanten lebenden Zellen zum Nachweis von xenobiotischen Stoffen sowie Anordnung und Testkit zur Durchführung des Nachweisverfahrens

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT321257B (de) 1971-05-26 1975-03-25 Koreska Gmbh W Anlage zur Rückgewinnung flüchtiger Lösungsmittel
JPS57198544A (en) * 1981-05-28 1982-12-06 Sony Corp Manufacture of magnetic recording medium
DE3240063A1 (de) 1981-11-02 1983-05-26 Basf Ag, 6700 Ludwigshafen Vorrichtung zur herstellung eines magnetogrammtraegers
JPS5880136A (ja) * 1981-11-02 1983-05-14 Fuji Photo Film Co Ltd 磁気記録材料の製造方法
JPH0656656B2 (ja) * 1983-10-03 1994-07-27 富士写真フイルム株式会社 磁気記録媒体の製造方法
JPS6292132A (ja) * 1985-10-18 1987-04-27 Fuji Photo Film Co Ltd 磁気記録媒体の製造方法
US4923766A (en) * 1988-03-29 1990-05-08 Canon Kabushiki Kaisha Process for preparing magnetic recording
GB8916806D0 (en) * 1989-07-22 1989-09-06 Univ Wales Medicine Modified proteins
DE4009797A1 (de) * 1990-03-27 1991-10-02 Pagendarm Gmbh Verfahren und anordnung zum kondensieren von dampffoermigen substanzen
AU677834B2 (en) * 1993-04-07 1997-05-08 Cancer Research Ventures Limited Methods for screening of substances for therapeutic activityand yeast for use therein
AU694745B2 (en) * 1993-09-10 1998-07-30 Trustees Of Columbia University In The City Of New York, The Uses of green fluorescent protein
DE69534920T2 (de) * 1994-07-22 2007-04-05 University Of North Carolina Src SH3 BINDENDE PEPTIDE UND VERFAHREN ZU IHRER ISOLIERUNG UND VERWENDUNG
US6184205B1 (en) * 1994-07-22 2001-02-06 University Of North Carolina At Chapel Hill GRB2 SH3 binding peptides and methods of isolating and using same
US5874231A (en) * 1994-08-22 1999-02-23 Mcgill University Methods of screening for non-hormone compounds which effect modulation of polypeptide translation
US5958713A (en) 1995-01-31 1999-09-28 Novo Nordisk A/S Method of detecting biologically active substances by using green fluorescent protein
ATE211506T1 (de) * 1995-01-31 2002-01-15 Bioimage As Ein verfahren zum nachweis biologisch aktiver substanzen
DE69604298T2 (de) * 1995-09-22 2000-05-18 Bioimage A/S, Soeborg Varianten des grünen fluoreszenzproteins, gfp
WO1997020931A1 (en) * 1995-12-08 1997-06-12 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Method and compositions for monitoring dna binding molecules in living cells
US5874304A (en) * 1996-01-18 1999-02-23 University Of Florida Research Foundation, Inc. Humanized green fluorescent protein genes and methods
US5989835A (en) * 1997-02-27 1999-11-23 Cellomics, Inc. System for cell-based screening
EP0915989B1 (en) * 1996-07-16 2010-06-02 The Regents Of The University Of California Assays for protein kinases using fluorescent protein substrates
WO1998030715A1 (en) * 1997-01-07 1998-07-16 California Institute Of Technology Optical sensors of cell signaling
WO1998038490A1 (en) * 1997-02-27 1998-09-03 Cellomics, Inc. A system for cell-based screening
US6416959B1 (en) * 1997-02-27 2002-07-09 Kenneth Giuliano System for cell-based screening
DK0986753T4 (da) * 1997-04-07 2005-12-19 Bioimage As Fremgangsmåde til uddragning af kvantitativ information, hvad angår en påvirkning af et cellulært respons
WO2000049183A1 (en) * 1999-02-17 2000-08-24 Clontech Laboratories, Inc. FLUORESCENCE RESONANCE ENERGY TRANSFER DETECTION OF cAMP IN LIVING CELLS USING GFP VARIANTS
US6573059B1 (en) * 1999-06-04 2003-06-03 Rmf Dictagene S.A. Use of the regulatory subunit of the camp dependent protein kinase (PKA) from dictyostelium for camp measurements

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015066706A2 (en) 2013-11-04 2015-05-07 Montana Molecular Llc GENETICALLY ENCODED FLUORESCENT SENSORS FOR DETECTING LIGAND BIAS AND INTRACELLULAR SIGNALING THROUGH cAMP PATHWAYS
EP3738971A1 (en) 2013-11-04 2020-11-18 Montana Molecular LLC Genetically encoded fluorescent sensors for detecting ligand bias and intracellular signaling through camp pathways

Also Published As

Publication number Publication date
EP1199564A3 (en) 2002-05-08
US6518021B1 (en) 2003-02-11
ES2173573T3 (es) 2002-10-16
DK0986753T3 (da) 2002-07-22
DE69804446T2 (de) 2002-11-07
DE1199564T1 (de) 2003-11-27
EP0986753B1 (en) 2002-03-27
DE69824763D1 (de) 2004-07-29
ES2191575T3 (es) 2005-02-01
ATE269975T1 (de) 2004-07-15
ATE354089T1 (de) 2007-03-15
ES2173573T5 (es) 2006-03-01
WO1998045704A3 (en) 1999-04-22
DE69804446D1 (de) 2002-05-02
EP1435519B1 (en) 2007-02-14
EP1435519A1 (en) 2004-07-07
EP0986753B2 (en) 2005-08-10
US20090023598A1 (en) 2009-01-22
DK0986753T4 (da) 2005-12-19
DE69824763T2 (de) 2005-07-07
CA2286293A1 (en) 1998-10-15
EP0986753A2 (en) 2000-03-22
EP1199564A2 (en) 2002-04-24
US20030082564A1 (en) 2003-05-01
PT986753E (pt) 2002-09-30
DE69837118D1 (de) 2007-03-29
PT1199564E (pt) 2004-10-29
DE69804446T3 (de) 2006-08-24
WO1998045704A2 (en) 1998-10-15
DE69837118T2 (de) 2007-12-27
ATE215227T1 (de) 2002-04-15
US8058008B2 (en) 2011-11-15
JP2001522454A (ja) 2001-11-13
EP1199564B1 (en) 2004-06-23
DK1435519T3 (da) 2007-06-11
ES2191575T1 (es) 2003-09-16
AU6820998A (en) 1998-10-30

Similar Documents

Publication Publication Date Title
CA2263883C (en) Kuz, a novel family of metalloproteases
JP4511033B2 (ja) Ｆａｃｓを用いて細胞表現型を変化し得る生物活性剤についてスクリーンする方法
US6518021B1 (en) Method for extracting quantitative information relating to an influence on a cellular response
Hama et al. PKC signaling mediates global enhancement of excitatory synaptogenesis in neurons triggered by local contact with astrocytes
US8114581B2 (en) Methods and compositions for detecting neoplastic cells
JP4295513B2 (ja) ミニ細胞ディスプレイを用いるペプチドディスプレイライブラリーをスクリーニングする方法
CN1289525C (zh) T2r,一类味觉受体
CA2348132C (en) A system for cell-based screening
EP1668161B1 (en) Fragment complementation assays for g-protein-coupled receptors and their signaling pathways
CA2484115C (en) Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases
JP2003526772A (ja) 細胞ベースのスクリーニング用のシステム
CA2281895C (en) Ikb kinases
CN101058605A (zh) T2r，一类味觉受体
US6485922B1 (en) Methods for detecting compounds which modulate the activity of an LPA receptor
EP2187213B1 (en) Methods for detecting interactions between two and more polypeptides
DK2687847T3 (en) PROBE TO ANALYZE BIOLOGICAL Tissue AND PROCEDURE FOR USING SAME
CA2346937A1 (en) Specific therapeutic interventions obtained by interference with redistribution and/or targeting
CA2480616A1 (en) Specific markers for diabetes
US20040137597A1 (en) Substrates of N-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrates
JP2005501552A (ja) 高スループット小分子薬物発見のための培養ヒト肥満細胞および好塩基球の産生
CA2462598A1 (en) A method of detecting intracellular protein-protein interactions using three heterologous conjugates
CA2450698A1 (en) A method for screening substances for effect on camp levels based on intracellular translocation of pka
CA2526515A1 (en) Methods for screening inhibitors of apoptosis
CA2384981A1 (en) P-glycoproteins and uses thereof
CA2486538A1 (en) Pain signaling molecules

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20180409